US Patent Issued to INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY on April 14 for "Method for predicting and improving treatment response to intestinal microbiome-based cancer immunotherapy and method for screening for candidate prebiotics" (South Korean Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,601,002, issued on April 14, was assigned to INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (Seoul, South Korea).

"Method for predicting and improving treatment response to intestinal microbiome-based cancer immunotherapy and method for screening for candidate prebiotics" was invented by In Suk Lee (Seoul, South Korea), Sang Jun Ha (Seoul, South Korea), Chan Yeong Kim (Seoul, South Korea), Hye Ryun Kim (Seoul, South Korea) and Beung Chul Ahn (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a method for predicting a treatment response to cancer immunotherapy, the method comprising a step of evaluating, from fe...